CD8A and neoplasm: It is well established that CD8+ TIL that coexpress high levels of inhibitory receptors (including PD-1 and Tim-3) exist in a terminally differentiated, exhausted state (Tex-term) in human cancer patients and murine tumor models (54, 55).